Source:http://linkedlifedata.com/resource/pubmed/id/21092188
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-12-14
|
pubmed:abstractText |
MicroRNAs are important gene regulators that potentially play a profound role in tumorigenesis. Increasing evidence indicates that miR-145 is a tumor suppressor capable of inhibiting breast and colon cancer cell growth both in vitro and in vivo. However, the biological function of miR-145 in non-small cell lung cancer (NSCLC) is largely unknown. In colon cancer cells, c-Myc is a confirmed direct target for miR-145. The aim of this work was to investigate the effect of miR-145 and c-Myc on proliferation of NSCLC cells, using the NSCLC cell lines A549 and H23 as models. We determined the expression level of miR-145 in tumor tissues relative to adjacent non-tumor tissues, and in NSCLC cell lines relative to non-malignant lung cells. Downregulation of miR-145 was seen in tumor tissues and the two NSCLC cell lines by real-time quantitative reverse transcription polymerase chain reaction. MTT and focus formation assays were conducted to measure cell proliferation rates. Cell growth was inhibited and the G1/S transition was blocked by miR-145 in transfection assays of A549 and H23 cells. We further showed that c-Myc was a direct target for miR-145. Introduction of miR-145 dramatically suppressed the c-Myc/eIF4E pathway, which was demonstrated to be crucial for cell proliferation in NSCLC cells. Furthermore, we found that CDK4 was regulated by miR-145 in cell cycle control. Taken together, our study results demonstrate that miR-145 inhibits proliferation of NSCLC cells through c-Myc. Increasing miR-145 expression may provide a novel approach for the treatment of NSCLC.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1756-9966
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
151
|
pubmed:meshHeading |
pubmed-meshheading:21092188-Blotting, Western,
pubmed-meshheading:21092188-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21092188-Cell Proliferation,
pubmed-meshheading:21092188-Gene Expression Profiling,
pubmed-meshheading:21092188-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:21092188-Humans,
pubmed-meshheading:21092188-Lung Neoplasms,
pubmed-meshheading:21092188-MicroRNAs,
pubmed-meshheading:21092188-Oligonucleotide Array Sequence Analysis,
pubmed-meshheading:21092188-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:21092188-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21092188-Transfection
|
pubmed:year |
2010
|
pubmed:articleTitle |
miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
|
pubmed:affiliation |
National Clinical Research Base of Traditional Chinese Medicine, Zhejiang Hospital of Traditional Chinese Medicine, Zhejiang Chinese Medical University, Hangzhou 310006, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|